Sanofi
SNY
SNY
484 hedge funds and large institutions have $11.5B invested in Sanofi in 2017 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 145 increasing their positions, 171 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
4% less call options, than puts
Call options by funds: $30.7M | Put options by funds: $32M
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
15% less repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 171
Holders
484
Holding in Top 10
9
Calls
$30.7M
Puts
$32M
Top Buyers
| 1 | +$112M | |
| 2 | +$39.8M | |
| 3 | +$39.7M | |
| 4 |
BlackRock
New York
|
+$34.1M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$25.1M |
Top Sellers
| 1 | -$105M | |
| 2 | -$66.7M | |
| 3 | -$62.5M | |
| 4 |
SAC
Smith Affiliated Capital
New York
|
-$59.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$59.7M |